Sulfonylureas: Second-line agents like glipizide and glimepiride fall under the category of sulfonylureas, which function by stimulating insulin secretion and are commonly used in the treatment of type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.